Clinical trial
Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour: Retrospective Study at the University Hospitals of Strasbourg
NCT05542524 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour: Retrospective Study at the University Hospitals of Strasbourg
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- August 31, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.